SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection.
Tsai TY, Huang MT, Sung PS, Peng CY, Tao MH, Yang HI, Chang WC, Yang AS, Yu CM, Lin YP, Bau CY, Huang CJ, Pan MH, Wu CY, Hsiao CD, Yeh YH, Duan S, Paulson JC, Hsieh SL.
Tsai TY, et al.
J Clin Invest. 2021 Jun 1;131(11):e141965. doi: 10.1172/JCI141965.
J Clin Invest. 2021.
PMID: 34060491
Free PMC article.